Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Seres Therapeutics Inc (NQ: MCRB )

0.7295 -0.0305 (-4.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,807,566
Open 0.7500
Bid (Size) 0.7050 (3)
Ask (Size) 0.7400 (6)
Prev. Close 0.7600
Today's Range 0.6955 - 0.7858
52wk Range 0.5400 - 6.730
Shares Outstanding 127,901,391
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
From Seres Therapeutics, Inc.
Via Business Wire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Seres Therapeutics, Inc.
Via Business Wire

Performance

YTD
-47.89%
-47.89%
1 Month
-7.35%
-7.35%
3 Month
-39.71%
-39.71%
6 Month
-52.48%
-52.48%
1 Year
-88.78%
-88.78%

More News

Read More
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Seres Therapeutics, Inc.
Via Business Wire
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Seres Therapeutics's Earnings: A Preview
Via Benzinga
Gold Price Alert: Gold Spot Prices Just Hit a Record High Today
Via InvestorPlace
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
From Seres Therapeutics, Inc.
Via Business Wire
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
From Seres Therapeutics, Inc.
Via Business Wire
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
From Seres Therapeutics, Inc.
Via Business Wire
Earnings Scheduled For March 5, 2024
Via Benzinga
Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
From Seres Therapeutics, Inc.
Via Business Wire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Seres Therapeutics, Inc.
Via Business Wire
Why Is Microbiome-Based Seres Therapeutics Stock Trading Higher Today?
Via Benzinga
Exposures Product Safety
Dow Tumbles Over 200 Points; US Trade Gap Narrows In November
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
From Seres Therapeutics, Inc.
Via Business Wire
Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Seres Therapeutics, Inc.
Via Business Wire
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
From Seres Therapeutics, Inc.
Via Business Wire
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
From Seres Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Nasdaq Gains 1%; US Adds 150,000 Jobs In October
Via Benzinga
Topics Stocks
Exposures US Equities
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.